Improving Kangaroo Care to Prevent Infections in High-risk Infants in NICUs
Official title: Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in Neonatal Intensive Care: a Pragmatic, Multicentre, Parallel Cluster Randomised Hybrid Implementation-effectiveness Study.
Run by PENTA Foundation · NCT05993442 · Data updated 2026-11-12
This study is testing whether improved Kangaroo Care can help prevent infections in high-risk infants in neonatal intensive care units.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 32 Weeks |
| Sex | All |
| Enrollment | 3080 (estimated) |
| Sponsor | PENTA Foundation Research network |
| Locations | 24 sites (Athens and 23 other locations) |
| Status | Recruiting |
| Started | May 28, 2024 |
| Main results expected | April 2026 |
| Study ends | May 2026 |
| Registry record updated | March 25, 2026 |
| Trial ID | NCT05993442 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are high-risk infants admitted to neonatal intensive care units, particularly those born extremely premature.
✕Probably not a fit
Patients who are not admitted to participating NICUs or those who do not meet the criteria for high-risk infants may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The NeoDeco trial is a multicenter, cluster-randomized study conducted across 24 neonatal units in five European countries. It aims to implement optimized Kangaroo Care (KC) to reduce severe infections and resistant bacterial colonization among high-risk infants in neonatal intensive care units (NICUs). The study involves a baseline assessment, a wash-in period for training, and a 10-month intervention period where KC will be continuously applied. Data on clinical outcomes and bacterial colonization will be collected from all eligible infants during the study.
Why it matters
Potential benefit: If successful, this study could significantly reduce the incidence of severe infections and improve health outcomes for high-risk infants in NICUs.
How similar studies have gone: Previous studies have shown promising results with similar approaches to Kangaroo Care, indicating potential for success in this novel implementation.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA 1\. Site level 1a. Neonatal unit that provide routinely cares for extremely premature infants (\<28 weeks' gestation). 1b. Minimum capacity of 12 beds. 1c. Access to a -70 to -80°C freezer for storage of research samples 1d. Willing to implement optimised KC if allocated to the intervention group. 1e. Willing to commit to offering the minimum expected target duration or an increase of 50% if neonatal unit is already offering \>67% of the minimum expected target duration, if allocated to the intervention arm. 1f. Prepared to implement NeoIPC surveillance. 1. g. Adequate resources and expertise and approvals from relevant Research Ethics Committees, as appropriate. 2. Infant level 2a. All high-risk infants (born at \<32 weeks' gestation) admitted to participating neonatal units, regardless of complexity of care, anticipated hospitalisation duration, room type, or whether admitted directly after birth. EXCLUSION CRITERIA 1 Site level 1. a. Participation in other research that could directly influence the study intervention or outcomes. 2. a. Average StSC duration already exceeding 18 hours per day. 3. a. Anticipated major changes in resistant bacterial colonisation pressure during the study 2 Infant level 2a. No infant-level exclusion criteria for data collection. We exclude infants from individual data and sample collection if their parents or legal guardians do not provide written informed consent. These infants contribute to cluster-aggregated outcomes.
Where it's running
-
Aglaia Kyriakou Children's Hospital
Athens, Greece Recruiting -
University General Hospital of Patras
Pátrai, Greece Recruiting -
Azienda Ospedaliera Universitaria S.Anna di Ferrara
Ferrara, Italy Recruiting -
Azienda Ospedaliera Universitaria di Modena
Modena, Italy Recruiting -
Ospedale Universitario Policlinico Paolo Giaccone
Palermo, Italy Recruiting -
Ospedale San Bortolo di Vicenza
Vicenza, Italy Recruiting
Show 18 more locations
-
Hospital General Universitario Alicante
Alicante, Spain Recruiting -
Cruces University Hospital
Bilbao, Spain Recruiting -
Hospital Regional Universitario de Málaga (Carlos Haya)
Málaga, Spain Recruiting -
Birmingham Heartlands Hospital
Birmingham, United Kingdom Recruiting -
University Hospitals Coventry and Warwickshire
Coventry, United Kingdom Recruiting -
City St George's, University of London
London, United Kingdom Recruiting -
St Mary's Hospital
Manchester, United Kingdom Recruiting -
Norfolk and Norwich University Hospital NHS Foundation Trust
Norwich, United Kingdom Recruiting -
University General Hospital Attikon
Attiki, Greece Completed -
University Hospital of Heraklion
Heraklion, Greece Completed -
Ioannina University Hospital
Ioannina, Greece Completed -
Hippokration Hospital - Thessaloniki
Thessaloniki, Greece Completed -
Papageorgiou Hospital
Thessaloniki, Greece Completed -
University of Basel Children's Hospital
Basel, Switzerland Completed -
Inselspital - University Hospital of Bern
Bern, Switzerland Completed -
Hôpitaux Universitaires de Genève
Geneva, Switzerland Completed -
Children's Hospital of Eastern Switzerland St.Gallen
Sankt Gallen, Switzerland Completed -
Universitätsspital Zürich - University Hospital Zurich
Zurich, Switzerland Completed
Study contacts
- Study coordinator: Selene Parenti
- Email: selene.parenti@pentafoundation.org
- Phone: +39 378 309 4518
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Antibiotic Prophylaxis Before Simple Tooth Extraction in Immunosuppressed Patients with Autoimmune Rheumatic Diseases
This trial tests whether giving a single dose of amoxicillin before a simple tooth extraction can prevent infections in adults with autoimmune rheumatic diseases who are on immunosuppressive therapy.
-
Using Negative Pressure Therapy to Prevent Infections in Surgical Wounds
This study is testing if using Negative Pressure Therapy can help prevent infections in surgical wounds for people who have had laparotomy surgery.
-
Identifying biomarkers for diagnosing sepsis in the emergency room
This study is trying to find out if certain immune responses can help doctors spot sepsis in patients with infections when they arrive at the emergency room.
-
Comparing two methods to prevent infection in ACL reconstruction surgery
This study is testing whether using grafts soaked in vancomycin can better prevent infections after ACL surgery compared to regular antibiotics for patients aged 20 to 45.
-
Molecular culture for diagnosing sepsis in children
This study is testing a faster way to diagnose sepsis in newborns and children by using a new blood test to see if it can identify infections more quickly than the usual method.
-
Effect of early antibiotics on patients with out-of-hospital cardiac arrest
This study is testing if not giving antibiotics to adults who have had a cardiac arrest outside the hospital is just as safe and effective as giving them early antibiotic treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.